|
|
Article: Chiron: No Begrivac Due For Overseas This Season.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
West Coast Editor
Like a persistent bug, Chiron Corp.'s problems related to the influenza vaccine remain with the company, although Wall Street seems to be taking the latest unfavorable news in stride.
Chiron said no Begrivac flu vaccine, which the company has been making for the German and UK markets, will be available this year. Earlier, Chiron had said production for the 2005-2006 flu season would drop from about 12 million doses to about 4 million because of manufacturing problems. (See BioWorld Today, July 18, 2005.)
The company's stock (NASDAQ:CHIR) closed Wednesday at $35.89, unchanged, though analyst Jennifer Chao of Deutsche Bank wrote ...